Company Directory / biotechnology

PrivateFor profitbiotechnologyCambridge, United States
Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.
Size
11-50 people: larger than 33% of companies with a size listed
Age
6 years old.
Reach
Website ranked #5,434,883 in the world for traffic, about 1k visits a month.
BiopharmaBiotechnologyMachine Learning
Funding, as listed
$37M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Nabla Bio, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Nabla Bio secured $26 million in Series A funding and announced collaborations with AstraZeneca, Bristol Myers Squibb, and Takeda for generative protein design.
Summaries written by the source dataset, not by us, and not checked.
biotechnology in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.